Loading clinical trials...

ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week | Clinical Trials | Clareo Health

TERMINATEDPHASE4

ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week

Record on Satisfaction of Patients With Actonel 35 mg Once a Week

NCT00544180•Sanofi

Summary

To determine the satisfaction of subject with Actonel 35 mg Once a Week in the treatment of post-menopausal osteoporosis. Open, non-controlled, multi-center study.

Eligibility

Age

55 - 80 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Postmenopausal ambulatory women
•Established osteoporosis

Exclusion Criteria

•History of cancer: basal cell or squamous cell carcinoma-documented 6-month remission,
•Diagnosis of hypocalcemia, hyperparathyroidism, hyperthyroidism
•The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Locations (1)

Sanofi-Aventis

Netanya, Israel

Key Dates

Start Date

May 1, 2005

Primary Completion Date

September 1, 2006

Last Updated

September 25, 2009

Enrollment

ACTUAL participants

Conditions

Osteoporosis

Interventions

Risedronate

DRUG

OsteoPorotic fracTure preventION System (OPTIONS) Research Study

NCT06731608

OsteoporosisLower Limb Fracture

View study

RECRUITINGPHASE4

Step-down Therapy After Long-term Osteoporosis Treatment

NCT07281586

Osteoporosis

View study

RECRUITING

Smart Wearable Device (gaitQ): Walk Better Project

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 25, 2009Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week

Inclusion Criteria

Exclusion Criteria

OsteoPorotic fracTure preventION System (OPTIONS) Research Study

Step-down Therapy After Long-term Osteoporosis Treatment

Smart Wearable Device (gaitQ): Walk Better Project

Automated Bone Age Estimation From Noncontrast Abdominal CT Using Deep Learning

Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship

Clinical Study to Estimate Bone Mineral Density With the POROUS Ultrasound Device